RPG Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

13.23

13.23

13.23

13.23

13.23

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

361.62

294.37

242.54

203.22

163.34

Loan funds

Secured loans

-

0.01

0.29

1.26

6.64

Unsecured loans

-

-

-

-

-

Total

374.85

307.61

256.06

217.71

183.21

Uses of funds

Fixed assets

Gross block

170.99

176.14

149.29

150.19

150.54

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

57.46

51.88

45.58

36.89

27.65

Net block

113.53

124.26

103.71

113.30

122.89

Capital work-in-progress

96.31

25.44

31.06

11.77

9.98

Investments

91.16

58.43

-

-

-

Net current assets

Current assets, loans & advances

211.87

211.22

209.84

178.32

133.86

Less : current liabilities & provisions

138.02

111.74

88.55

85.68

83.52

Total net current assets

73.85

99.48

121.29

92.64

50.34

Miscellaneous expenses not written

-

-

-

-

-

Total

374.85

307.61

256.06

217.71

183.21

Notes:

Book value of unquoted investments

91.16

58.43

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

22.26

33.52

15.12

16.98

14.20

Number of equity sharesoutstanding (Lacs)

165.39

165.39

165.39

165.39

165.39